Kabir Nath has approximately thirty years of experience in the biopharmaceutical and medical device industry. Prior to joining COMPASS, Kabir was Senior Managing Director of global pharmaceuticals at Otsuka Pharmaceutical Co., Ltd. and, before that, President and CEO of Otsuka’s North America Pharmaceutical Business, where he led the development of pharmaceutical products and digital solutions addressing complex mental health needs. Kabir has also held various leadership positions at Bristol Myers Squibb, a global biopharmaceutical company focused on innovative medicines for patients with serious diseases. Kabir holds an MA from the University of Cambridge and an MBA from INSEAD.